Leptospirosis is an important global human and veterinary health problem. Humans can be infected by exposure to chronically infected animals and their environment. An important focus of the current leptospiral research is the identification of outer mem brane proteins (OMPs). Due to their location, leptospiral OMPs are likely to be relevant in host-pathogen interactions, hence their potential ability to stimulate heterologous immunity. The existing whole-genome sequence of Leptospira interrogans serovar Copen hagen! offers a unique opportunity to search for cell surface proteins. Predicted genes encoding potential surface proteins were amplified from genomic DNA by PCR methodology and cloned into an Escherichia coli expression system. The partially purified recombinant proteins were probed by Western blotting with sera from human patients diagnosed with leptospirosis. Sixteen pro teins, out of a hundred tested, were recognized by antibodies present in human sera. Four of these proteins were conserved among eight serovars of L. interrogans and absent in the non-pathogenic Leptospira biflexa. These proteins might be useful for the diagnosis of the disease as well as potential vaccine candidates.
disease became prevalent in cities with sanitation prob lems and large population of urban rodent reservoirs, which contaminate the environment through their urine [4] . The incidence of leptospirosis remains underesti mated in part due to the broad spectrum of signs and symptoms that patients may present. Children primarily show fever, vomiting, headache, diarrhea, abdominal and generalized muscle pain, whereas adults have fever, headache, anorexia, muscle pain and constipation [4, 5] . Five percent to 15% of the cases evolve more severely presenting hemorrhages with renal and hepatic failure, a condition known as Weil's syndrome [4] , with a mor tality rate of 5-40%. Leptospirosis has also a great eco nomic impact in the agricultural industry since the disease affects the livestock inducing abortions, still births, infertility, reduced milk production and death [3, 4] .
Currently available veterinarian vaccines are based on inactivated whole cell or membrane preparations of pathogenic leptospires. These types of vaccine con fer protective responses through induction of antibod ies against leptospiral lipopolysaccharide [6] . However, these vaccines fail to induce long-term protection against infection and do not provide cross-protective immunity against leptospiral serovars not included in the vaccine preparation. There is a large number of pathogenic serovars (>200) which imposes a major limitation to the production of a multi-serovar compo nent vaccine and to the development of immunization protocols based on whole cell or membrane prepara tions. In humans, a prototype vaccine has been tested in China but children under 14 years were not pro tected [7] . A vaccine licensed for human is still long awaited [4]- The advent of whole-genome sequencing has made an impressive impact in the microbial field landscape. The complete genomic sequence of Neisseria meningit idis serogroup B offered a new strategy for the identi fication of vaccine candidates [8] . This landmark approach, now called reverse vaccinology, has been applied in the last few years revolutionizing the vac cine research area [9, 10] . The design of vaccines is based on bioinformatic tools for the prediction of po tential antigens in silico, hence narrowing down the universe to be tested. In addition, this approach has the advantage of revealing proteins independently of their abundance and without the need of growing the microorganism in vitro [11] .
In the present study, we describe 16 new leptospiral membrane-associated proteins selected from the genome of L. interrogans serovar Copenhagen! [12, 13] . The rationale for the choice of these predicted coding se quences is that surface-associated molecules are poten tial targets for inducing immune responses in animals and may serve as vaccines against disease and/or for use in diagnostic tests.
Materials and methods

Bacteria
L. interrogans serovar Copenhageni sequenced strain (Fiocruz Ll-130) was provided by Dr. A.I. Ko (CPqGM/FIOCRUZ/MS). The strain was isolated as described [12] . L. interrogans serovars Canicola, Icterohaemorrhagiae, Copenhageni, Bratislava, Hardjo, Autumnalis, Pomona, Pyrogenes, Grippotyphosa and Leptospira biflexa serovar Patoc were maintained in one of our laboratories (S.A.V., Faculdade de Medicina Veterinària, Universidade de Sào Paulo, SP, Brazil).
In silico identification of surface proteins
Protein coding genes from the L. interrogans genome sequence were identified using GeneMark and Glimmer [14] . The PSORT program [15] (http://psort.nibb.ac.jp/) was then used to predict the localization of the coded proteins within the bacterium. Public and custom se quence-specific search algorithms were used for identifi cation of sequence motifs including signal peptides, lipoprotein cleavages sites and transmembrane domains (http://www.cbs.dtu.dk/services/TMHMM) [16] and (http://www.cbs.dtu.dk/services/SignalP) [17] . In addi tion, putative proteins, homologous to surface proteins previously characterized as virulence factors in other organisms, were searched for by blast analysis (http:// www.ncbi.nlm.nih.gov/BLAST/) [18] . In this work, the predicted coding sequences are referred to according to their genome nomenclature, LIC [12] .
Cloning, expression and purification
Cloning techniques were performed according to Sambrook et al. [19] . For the expression of the selected predicted coding sequences the Gateway® (Invitrogen) cloning and expression system was used. Each selected DNA sequence was amplified by PCR from Leptospira genomic DNA using Pfx DNA polymerase (Invitrogen) and primers specially designed following the manufac turer recommendations. In this system, the PCR prod ucts are first cloned into pENTR TOPO vector (Invitrogen). The correct orientation is obtained by add ing four bases to the forward primer (CACC) which an neals to a complementary overhang in the cloning vector (GTGG). In Table 1 , there is a list of primers for PCR amplification of 17 coding sequences which became of special interest in this report. When necessary, DNA bands were extracted from agarose gel using Concert purification system (Gibco BRL) following the manu facture's protocol. The sequence of the cloned leptospira DNA insert was confirmed by sequencing and trans ferred by recombination reaction by LR Clonase (Invit rogen) to the Escherichia coli expression vector pDEST17. The vector containing the correct DNA se quence was cloned into E. coli BL21(DE3) (Novagen) for protein expression as previously described [20] . The production of recombinant proteins was achieved by the addition of isopropyl P-D-thiogalactoside (IPTG) to the medium. The pDEST17 vector allows the expres sion of recombinant proteins with 6 x His-tag at the Nterminus. Most of the assays were performed in high throughput scale with 96 samples each round. The first screening to check the protein expression was done by SDS-PAGE with total protein extracts from each clone. Proteins from expressing clones were purified from the pellets of the cell extracts, by solubilization in 8 M urea, followed by metal affinity chromatography using QIAfilter 96 plates Ni-nitrilotriacetic acid resin superflow (Qiagen) as described by the manufacturer. In brief, contaminants were washed away with 10 vol. of binding buffer, 20 mM Tris, 500 mM NaCl, containing 5 or 20 mM imidazole. Recombinant protein samples were eluted with 5 vol. of the same buffer but with 1 M imid azole. Eluted fractions were analyzed by SDS-PAGE, through 12-15% (wt/vol) acrylamide concentration according to the expected molecular mass of the proteins.
Mice antisera against recombinant proteins
Groups of 5, 6-8 weeks female BALB/c mice, (Insti tute Butantan, Sao Paulo, SP, Brazil) were immunized subcutaneously with approximately 15 pg of each re combinant protein with complete Freund's adjuvant. After 21 days, mice were boosted with the same amount of protein in incomplete Freund's adjuvant. Twenty eight days following the booster the animals were bled and immune titers were determined by antibody capture endpoint enzyme-linked immunosorbent assay (ELISA). The control group was inoculated with PBS and adjuvant.
Recognition of recombinant proteins by sera from leptospirosis patients
Cell pellets of induced bacteria as well as purified pro teins were separated by 12-15% SDS-PAGE and electro transferred to nitrocellulose membrane for Western blotting assay. Membranes were blocked with PBS con taining 0.1% Tween 20 (PBS-T) and 5% nonfat dry milk; after which they were incubated with individual human serum (microscopic agglutination test -MATtitre of 25,000, Instituto Adolfo Lutz, Sao Paulo, SP, Brazil) from convalescent patients diagnosed with leptospirosis at 1:100 dilution. Goat anti-human IgG peroxidase-conjugate was used as secondary antibody at 1:1000 dilution in PBS-T. Proteins reacting with the antisera were de tected by reaction with DAB and H2O2 or with ECL Kit ( Amersham).
Recognition of proteins from leptospiral extracts by sera from mice immunized with recombinant proteins
Bacterial cultures of several leptospiral serovars were centrifuged and the cell pellets were resuspended and washed three times by centrifugation with PBS contain ing 5 mM MgCl2. The cell pellets were then resuspended in PBS containing 10% SDS and a sample from each serovar sample was applied on a 10% SDS-PAGE. Pro teins were transferred to nitrocellulose membrane and probed with serum obtained from mice immunized with each of the recombinant proteins.
Nucleotide sequence Accession Numbers
The sequences of the two chromosomes of L interro gans serovar Copenhagen! strain Fiocruz have been deposited in the GenBank database under Acces sion Nos. AE016823 and AE016824. The accession numbers for public data base for each protein sequence analyzed in this work are listed in Table 2 . The proteins can also be accessed by the genome nomenclature for the gene locus, LIC number (Leptospira interrogans Copenhageni).
Results
Identification of vaccine candidates from the leptospiral genome: in silico analysis
Our rationale for the selection of the predicted coding sequences is that surface associated molecules are poten tial targets for inducing immune responses in the host [8] [9] [10] [11] . These sequences could be identified in the gen ome database by one or more sequence motifs com monly found in known surface proteins from other bacteria. A primary screening was performed using the Psort program [http://psort.nibb.ac.jp/] to identify puta tive proteins with predicted cellular localization from the inner to the outer bacterial membrane. Genes encod ing proteins with known cytoplasmic functions were ex cluded. In addition, we searched for exportation signal peptides, transmembrane domains, lipoprotein signa tures and homologies to known surface proteins [12] . The in silico approach resulted in a large number of genes covering ~20% of the total number of predicted proteins in the genome. From these sequences we fo cused the selection mainly on hypothetical, unknown proteins, having either signal peptide sequences or lipobox motifs [12] . 
Cloning and expression of vaccine candidates
Oligonucleotides for PCR amplifications (Table 1 ) were designed from the genome without the signal peptide sequences, which typically contain 18-28 nucleotides, as described in experimental procedures. From 206 selected coding sequences (see Table 1 , sup plementary data), more than 97% were amplified. The correct sequences were confirmed by DNA sequencing and 175 genes (84%) were successfully cloned into pENTR. The DNA inserts were transferred by recom bination from pENTR to pDEST17 expression vector. This E. colt vector expresses the recombinant proteins with six histidine residues at the N-terminus which al lows a rapid purification of the protein by metal che lating chromatography. We have expressed and purified 150 recombinant proteins with this system. A representative set of SDS-PAGE containing cell ex tracts from induced E. colt BL21(DE3) cultures expressing the recombinant proteins is shown in Fig.  1 . Based on the results obtained with the immune as says (see below), 16 proteins were found to be of spe cial interest and the data related to them are highlighted along this report. Some of these proteins are indicated in Fig. 1 .
The majority of the recombinant proteins were found to be insoluble in the pellets of bacterial cell ly sates, as evaluated by SDS-PAGE (not shown). The inclusion bodies were isolated, urea-solubilized and purified by metal affinity. The purified proteins were grouped according to their molecular mass and ana lyzed by SDS-PAGE. A representative set of these gels is shown in Fig. 2 , in which numbered lanes refer to proteins reactive to sera of leptospirosis patients (see below). (6) LipL53. M indicates the protein molecular mass marker.
Screening recombinant proteins for reactivity with leptospiral antisera
Purified proteins were screened for reactivity by immu noblotting with pooled sera from patients diagnosed with leptospirosis. The recombinant lipoprotein LipL32 was used as a positive control since it was shown to be immu nogenic and highly conserved among Leptospira patho genic serovars [20, 21] . A total of 16 proteins out of a hundred tested were recognized by sera from leptospiro sis's convalescent patients (Fig. 3) . Table 2 summarizes features of these sera-reactive recombinant proteins.
Features of the proteins recognized by antibodies
The recombinant proteins listed in Table 2 were rec ognized by human sera from patients diagnosed with leptospirosis. They are all predicted to be membrane proteins with a signal peptide of 20-36 amino acids, as indicated by the software described in Bendtsen et al. [17] . Seven of these proteins (indicated by ** in Table  2 ) are probably new leptospiral lipoproteins according to the criteria previously described [12, 22] . The signal peptides regions are characterized by a higher propor tion of hydrophobic amino acids, a lipoprotein signal peptidase and a cysteine to be lipidated [22] . No specific function could be attributed to these putative lipopro teins. LIC10054 encodes a rare lipoprotein domain to which homologs were already found in other microor ganisms according to GeneBank database [http:// www.ncbi.nlm.nih.gov/BLAST/] [18] . Interestingly, the protein named OMPL15 (LIC13008) did not match any sequence in the available protein databases and should be considered for further studies on protein func tion. The protein encoded by LIC10191 has been Purification of recombinant proteins. Representative SDS-PAGE containing samples of purified proteins obtained by high throughput metal affinity chromatography purification system. Proteins are assembled in the gels according to their expected molecular mass. Lane numbers refer to sera-reactive proteins: (1) OMPL15. (2) MPL17. (3) OMPL16. (4) OMPL30. (5) MPL21. (6) OMPL21. (7) LipL22. and (8) OMPL22. M indicates the protein molecular mass marker. recently characterized from L. interrogans serovar Manilae, strain UP-MMC, as a novel lipoprotein with an OmpA domain [23] . Three proteins out of the 16 were found to be hypothetical proteins conserved among other microorganisms, while five were hypothetical pro teins conserved only among Leptospira species (Table 2) , according to the currently available databases.
Conservation of antigenic proteins among leptospiral serovars
Protein expression in the most prevalent pathogenic serovars of L. interrogans is an important requirement for leptospiral vaccine candidates. In order to character-ize the conservation of the selected proteins we em ployed protein extracts from several L. interrogans serovars: Canicola, Icterohaemorrhagiae, Copenhageni, Bratislava, Hardjo, Autumnalis, Pomona, Pyrogenes, Grippotyphosa and the nonpathogenic strain L. biflexa serovar Patoc. Cell extracts were prepared from cultures of the different serovars and Western blot analysis was performed with polyclonal sera from mice immunized with each recombinant protein. The serological cross reactivity showed a high degree of conservation among four out of 10 proteins tested (Fig. 4) . Interestingly, none of these four proteins were present in the non pathogenic L. biflexa strain, suggesting that they may be relevant for pathogenesis. Most of the proteins reac- 
LipL32 (LIC11352)
five with human leptospirosis serum shared roughly comparable expression levels among the different sero vars tested, but LIC10508 and LIC10561 were more variable.
Discussion
Considering that L. interrogans has an AT rich gen ome, with a 35% G + C content, [12] , which imposes cer tain difficulties for primer design, it was above expectations to have amplified more than 97% of the 206 coding sequences, as well as to have expressed and purified more than 80% of the cloned products. By screening with immune sera from leptospirosis patients 16 proteins were identified as potential vaccine candi dates or to be used in diagnosis. The fact that these pro teins react with infected human sera not only shows their immune reactive properties, but also strongly sug gests that these proteins are expressed in the course of human infection. Interestingly, one of them (OMPL15) did not match at all any protein sequence in the public databases and deserves further studies to characterize its origin and function.
The central mechanism in pathogenesis of leptospiro sis, as in other spirochetal diseases such as Lyme disease and syphilis, is the ability of the pathogens to dissemi nate widely within the host during the early stage of infection [4] . Although surface-associated proteins that play a role in virulence have not been yet identified, it is assumed that they may mediate interactions that en able entry and dissemination through host tissues. Puta tive outer membrane proteins would be accessible to the immune response during host infection and therefore, constitute targets for immune protection through mech anisms such as antibody-dependent phagocytosis and killing mediated by complement. In this regard, a major limitation in the field of leptospirosis has been to iden tify membrane associated proteins through conventional biochemical and molecular methods. For instance, be fore the complete genome sequence of a leptospira was known, only 10 lipoproteins had been characterized through isolation of membrane fractions [24] [25] [26] [27] [28] [29] . Using the genome approach, we have identified 174 novel putative lipoproteins [12] . In addition, the identified lep tospiral proteins may also have diagnostic applications. At present, rapid and efficient diagnostic tests are not available for use in human and veterinary leptospirosis [1, 2, 4] . A proportion of these membrane proteins will be antigens expressed during infection and should be recognized by the host immune system. Therefore, they may serve as the basis to develop antigen-capture detec tion strategies or recombinant protein-based serologic tests.
Our results corroborate previous studies showing the advantages of using whole genome approach [10, 11] for the identification of novel vaccine antigens at a reason able cost and time compared with traditional strategies.
We believe this work represents an important contri bution to the leptospiral field. The proteins described herein may certainly be exploited for the establishment of a much-needed kit for diagnosis of leptospirosis. Fur thermore, these proteins may provide an optimal basis for the development of a new and effective vaccine that would help reduce the burden of leptospirosis.
